MedTrace Logo

Comparing Restriction Spectrum Imaging (RSI) to Conventional and Abbreviated Breast MRI for Breast Cancer Screening

NCT03495115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 460

Last updated 2026-04-17

Study results available
· View outcomes & findings →

Summary

This study is looking at a breast cancer screening technique, restriction spectrum imaging (RSI), as a possible alternative to the breast Magnetic Resonance Imaging (MRI) used by most healthcare professionals.

The technique involved in this study is:

-Restriction Spectrum Imaging (RSI)

Conditions

Interventions

DEVICE

MRI

A MRI uses a strong magnet to produce detailed pictures of the inside of your body.

DEVICE

RSI

RSI is a technique that aims to improve the pictures produced during a MRI exam.

Sponsors & Collaborators

Principal Investigators

  • Vandana Dialani, MD · Beth Israel Deaconess Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-18
Primary Completion
2023-12-30
Completion
2023-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03495115 on ClinicalTrials.gov